Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03728569 · ClinicalTrials.gov registry record · Early Phase 1

Skin Barrier Dysfunction and the Role of Skin Barrier Restoration

A Early Phase 1 study, sponsored by University of Michigan.

Terminated
Registry status
Early Phase 1
Development phase
14
Enrollment target

NCT03728569 is a Early Phase 1 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03728569, a Early Phase 1 study, was terminated before completion, sponsored by University of Michigan.

TERMINATED
Registry status
Early Phase 1
Development phase
14 participants
Enrollment target

Study Summary

The objective of this exploratory study is to gain an understanding of cutaneous and systemic inflammation and how restoration of the skin barrier through the use of moisturizer may restore the skin barrier function and reduce systemic inflammation in elderly humans compared to the young. The exploratory study will consist of three visits per subject. Subjects will be instructed to apply a moisturizer (Vanicream Moisturizing Skin Cream) over the entire skin surface from the neck down twice daily for up to 30 days.

Interventions

  • OTHER Vanicream Moisturizing Skin Cream
  • OTHER Vanicream Cleansing Soap

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2018-05-16
Est. Completion 2021-02-01
Phase Early Phase 1

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03728569

The ClinicalTrials.gov registry entry for NCT03728569 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Vanicream Moisturizing Skin Cream is the first listed.

NCT03728569 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03728569 about?

NCT03728569 is a clinical study titled "Skin Barrier Dysfunction and the Role of Skin Barrier Restoration". The objective of this exploratory study is to gain an understanding of cutaneous and systemic inflammation and how restoration of the skin barrier through the use of moisturizer may restore the skin barrier function and reduce systemic inflammation in elderly humans compared to the young. The explor...

What is the current status of trial NCT03728569?

This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 14 participants. The study started on 2018-05-16. Estimated completion is 2021-02-01.

What interventions are being tested in trial NCT03728569?

The interventions under investigation include: Vanicream Moisturizing Skin Cream (OTHER), Vanicream Cleansing Soap (OTHER).

Who is sponsoring clinical trial NCT03728569?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.